[Home ] [Archive]    
:: Home :: About Journal :: Registration :: Article Submission :: Contact us :: Site Map ::
:: Volume 9, Issue 1 (March 2017) ::
IJBC 2017, 9(1): 5-11 Back to browse issues page
Paraoxonase and Arylesterase Activities in Patients with Cancer
Mohammad Javad Khodayar , Mohammad Seghatoleslami , Maryam Salehcheh , Fatemeh Jalali *
School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Abstract:   (474 Views)

Background: Cancer has the highest disease-related mortality rate in Iran. Reduced activity of paraoxonase reported in patients with cancer may be due to a reduction in its antioxidant properties and a subsequent increased risk of developing cancer. We aimed to assess antioxidant and oxidative status in patients with cancer through measuring the activity of PON1 as an antioxidant enzyme and determining MDA as a marker of oxidative stress. 
Methods: This case-control study was conducted on 50 patients with colon, lung, blood or breast cancer and 50 age- and sex-matched healthy controls matching during 2014-2015. Paraoxonase-1 and arylesterase activities were measured with paraoxon and phenylacetate substrates and their malondialdehyde levels and serum lipid profile were determined through spectrophotometry.
Results: Serum paraoxonase activity was lower in patients with cancer (28.52±2.77 IU/L) compared with the healthy subjects (96.57±1.49 IU/L; P<0.0001). Similarly, serum arylesterase activity was lower in patients with cancer (49.27±2.90) than the controls (66.91±2.47; P<0.0001). MDA levels were higher in patients with cancer (1.3166±0.0876) than the healthy controls (0.9008±0.0452). The Mann-Whitney U-Test showed significant differences between the two groups in terms of their triglyceride levels (P<0.05). Although serum HDL levels were higher in the control group compared with the cases, the difference was not statistically significant (P>0.05). Serum VLDL, LDL and total cholesterol levels differed significantly between the two groups (P<0.05).
Conclusion: The results obtained showed a reduction in paraoxonase activity and an increased lipid oxidation in the patients with cancer and thereby reduced the antioxidant power of paraoxonase and weakened the body’s antioxidant system.

Keywords: Paraoxonase, Arylesterase, Malondialdehyde, Lipid profile, Cancer
Full-Text [PDF 504 kb]   (282 Downloads)    
: Research | Subject: Adults Hematology & Oncology
Received: 2016/09/6 | Accepted: 2016/12/15 | Published: 2017/04/3
Send email to the article author

Add your comments about this article
Your username or Email:

Write the security code in the box >



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khodayar M J, Seghatoleslami M, Salehcheh M, Jalali F. Paraoxonase and Arylesterase Activities in Patients with Cancer. IJBC. 2017; 9 (1) :5-11
URL: http://ijbc.ir/article-1-687-en.html
Volume 9, Issue 1 (March 2017) Back to browse issues page
مجله ی خون و سرطان ایران Iranian Journal of Blood and Cancer
Persian site map - English site map - Created in 0.05 seconds with 794 queries by yektaweb 3535